Vet Pathol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Majzoub, M.
Right arrow Articles by Hermanns, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Majzoub, M.
Right arrow Articles by Hermanns, W.
Vet Pathol 40:249-253 (2003)
© 2003 American College of Veterinary Pathologists

Histopathologic and Immunophenotypic Characterization of Extramedullary Plasmacytomas in Nine Cats

M. Majzoub, W. Breuer, S. J. Platz, R. P. Linke, W. Linke and W. Hermanns

Institute of Veterinary Pathology, University of Munich, Munich, Germany (MM, WB, SJP, WH); and Max-Planck-Institute of Biochemistry, Martinsried, Germany (RPL)


    Abstract
 Top
 Abstract
 Material and Methods
 Results
 Discussion
 References
 
To contribute to the existing body of knowledge in the literature on the apparently rare extramedullary plasmacytoma in cats, lymphoid tumors with plasmacytic cellular morphology taken from nine cats were examined. The paraffin-embedded material was investigated by standard hematoxylin and eosin, and special staining techniques (Giemsa, Congo-red, and periodic acid–Schiff reaction). The tumors also were examined immunohistochemically for the presence of immunoglobulin G, immunoglobulin A, immunoglobulin M, immunoglobulin light chains ({lambda}, {kappa}), various amyloid proteins, and FeLV-antigen (p27 protein). An immunoglobulin-producing tumor of plasmacellular origin (extramedullary plasmacytoma [EMP]) could be diagnosed in all cases on the basis of immunohistochemical light-chain expression. All but one of the neoplasms occurred in the skin of older, predominantly male cats. As in humans and dogs, the following types could be identified according to their morphologic features: mature type (two), cleaved type (two), asynchronous type (four), and polymorphous type (one). The tumor tissue of three cats revealed amyloid deposits, which were immunohistochemically diagnosed as AL{lambda}-amyloid in all three cases.


Key words: Amyloid; cats; extramedullary plasmacytoma; immunohistochemistry.

Plasmacytomas are neoplasms consisting mainly of plasma cells at varying stages of differentiation.11 The solitary myeloma and multiple myeloma are additional types of plasma-cell–derived tumor. The latter are primarily located in the bone marrow. Extramedullary plasmacytomas (EMPs) are characterized by their extraskeletal location.8,29 As defined by the World Health Organization, EMPs consist of atypical neoplastic plasma cells with monoclonal expression of immunoglobulin (Ig) light chains or heavy chains.15 They differ from other non-Hodgkin lymphomas by their predominantly postmitotic and terminally differentiated plasma cells. The main cellular function, production and secretion of Igs, is largely unaffected.22

Whereas the EMP is a frequent neoplasm in dogs,4,13,16,23,25–27 it is a sporadic tumor in man.3,7,29,30 Judging from the existing case reports involving only one or two animals, the incidence of EMP in cats seems to be low. Feline EMPs have been described as occurring in the skin,4,5,13,19 gastrointestinal tract,24,31 retroperitoneal space,14 upper lip, gingiva,9 and orbita.28

Affected cats were generally more than 10 years old; the average age of the animals was 10.6 years.13,19 A male predisposition could be clearly concluded from the literature (male to female ratio was 2:1). The European Short-Haired cat was the most commonly affected. One case each was reported in the Abyssinian,28 the Long-Haired, the Persian,9 and the Burmese13 breeds. Tumor-associated monoclonal gammopathy was reported in three cases.5,14,28

The literature is uniform in describing the morphology as a monomorphic population of plasma cells with isolated bi- or multinucleated giant cells.4,28,31

In several cases, immunohistochemistry revealed monoclonal expression of {lambda}-Ig light chains,4,6,9,19 whereas {kappa}-Ig light-chain expression was found in only one case.9 Ig heavy chains of the immunoglobulin G (IgG)9 and immunoglobulin (IgA)31 types also have been confirmed in the tumor cells. Amyloid deposits in feline EMPs were demonstrated by several authors,4,5,13,14,19,24 although the amyloid was identified as AL{lambda}-amyloid in only three cats.19,24 To exclude a multiple myeloma, some authors examined the bone marrow for tumor cell infiltrates in the cats.5,10,14,31

The aim of this retrospective study was to contribute to the existing body of knowledge in the literature on feline EMP by reporting on the morphologic and immunohistochemical findings in nine cats.


    Material and Methods
 Top
 Abstract
 Material and Methods
 Results
 Discussion
 References
 
The tissue samples of nine feline EMPs were either from the files of the Institute of Veterinary Pathology of the University of Munich (n = 7) or were samples provided by Dr. D. von Bomhard, collected from his Veterinary Pathology Practice (n = 2). Two of the cases were included in a previous publication.19 The diagnosis of EMP was based on plasmacytic morphology, and further characterization was based on immunohistochemistry.

Eight tumors occurred in the skin (see Results for details), and one had been removed from the oral cavity. Tissue samples were fixed in 5% buffered formaldehyde and embedded in paraffin. Subsequently, staining of 3-µm-thick sections was carried out with hematoxylin and eosin (HE) and Giemsa stain, as well as the PAS-reaction and Congo-red staining method.21

Immunohistochemistry

For immunohistochemistry, an indirect peroxidase method was chosen.17 The following cross-reacting rabbit-derived polyclonal antibodies were used: anti-human IgG (DAKO diagnostika GmbH, Hamburg, Germany; diluted 1:500); anti-human IgA (DAKO; diluted 1:500); anti-human IgM (DAKO; diluted 1:500); anti-human {lambda} light chains (DAKO; diluted 1:750); and anti-human {kappa} light chains (DAKO; diluted 1:500). Incubation with the primary antibody was followed by incubation with peroxidase–conjugated swine anti-rabbit Ig (DAKO; diluted 1:50). Tumors also were examined for the presence of feline leukemia-virus antigen (p27 protein) by incubation with polyclonal goat anti-p27 antibody (Biodesign, Dunn Labortechnik GmbH, Asbach, Germany; diluted 1:2,000). The secondary antibody was peroxidase–conjugated rabbit anti-goat Ig (DAKO; diluted 1:400). The reaction cascade was observed by incubation with diaminobenzidine-tetrahydrochloride (Fluka, Feinchemikalien GmbH, Neu-Ulm, Germany). Finally, the slides were counterstained with hematoxylin.

To identify the biochemical nature of the amyloid, monoclonal antibodies cross-reacting with animal amyloid were used together with the unlabelled immunoperoxidase (peroxidase–anti-peroxidase [PAP]) method, as summarized previously12: anti-human AL{lambda} (HAR; diluted 1:8,000); anti-human AL{lambda} (ULI; diluted 1:2,000); anti-equine AL{lambda} (HIP; diluted 1:2,000); anti-human AA (mc1; cell culture supernatant diluted 1:10); and anti-human AA (mc129; cell culture supernatant diluted 1:10). The bridging antibody was a sheep anti-mouse IgG prepared in-house (diluted 1:20), and the third antibody was a PAP complex (DAKO, diluted 1:100). The reaction was developed with aminoethylcarbazole and the slides were counterstained with acid hemalum.

The primary antibody was replaced by nonimmune sera of the same species for control purposes.


    Results
 Top
 Abstract
 Material and Methods
 Results
 Discussion
 References
 
An extramedullary plasmacytoma was diagnosed in the case of all nine tumors on the basis of the cellular morphology and the immunohistochemical reaction pattern with light-chain restriction, i.e., the monoclonal expression of an Ig light-chain type was considered to be a decisive diagnostic criterion (Figs 1–7). Six of the affected animals were European Short-Haired cats and two were Siamese cats. No information was available regarding the breed of the ninth cat. The cats were 6–20 years old, with an average of 8.2 years. Four of them were females and five were males. Eight tumors were localized in the skin of various body regions (paws, thorax, neck, shoulder, tail, metatarsus, and nose); one was removed from the oral cavity. The EMPs varied in diameter, the largest being 3.5 cm wide. The cut surface of the tumors had a firm consistency, and the epidermis of the cutaneous EMPs was ulcerated in six cats.



View larger version (139K):
[in this window]
[in a new window]
 
Fig. 1. Skin, paraffin section; European Short-Haired cat, 7-year-old spayed female. Feline extramedullary plasmacytoma (EMP, asynchronous type of tumor cells) with basophilic cytoplasm, a clear perinuclear halo, and a blastic nucleus with a central nucleolus. Giemsa. Bar = 20 µm.
Fig. 2. Immunohistochemical demonstration of Ig-{lambda}-light-chains in the cytoplasm of tumor cells. Same cat as in Fig. 1. Bar = 20 µm.
Fig. 3. Feline EMP with homogenous eosinophilic amyloid deposits. HE. Bar = 50 µm.
Fig. 5. Skin; European Short-Haired cat, 13-year-old castrated male. Congo red–staining of EMP, mature type of tumor cells. Bars = 20 µm.
Fig. 6. All Congo-red positive areas within the tumor are identified as amyloid by green-birefringence in polarized light. Same cat as in Fig. 5. Bars = 20 µm.
Fig. 7. Immunohistochemical identification of AL{lambda} amyloid with the anti-AL{lambda} antibody ULI. Same cat as in Fig. 1. Bar = 20 µm.

 
Histology

Histologically, the tumors were located in the corium and the subcutis of the skin or in the lamina submucosa of the oral cavity. They frequently expanded into the surrounding tissue, but a clearly infiltrative and destructive growth pattern was evident in only four cases. Invasion of blood vessels was not seen in any of the tumors. Inflammatory cellular infiltration at the tumor periphery consisted of macrophages, a few lymphocytes, and mast cells. In the areas of ulceration, tumor tissue was infiltrated by neutrophilic granulocytes.

According to the classification scheme of Bartl et al.2 and Platz et al.,20 four different types of EMPs could be ascertained on the basis of histologic and cytomorphologic criteria. They are as follows.

Mature type (n = 2). Morphologically, cells of this type did not differ from mature plasma cells (Marschalko cells). The mainly oval-shaped tumor cells displayed eccentric nuclei, many of them with characteristic chromatin clumping, giving rise to a "cartwheel" appearance, and a perinuclear halo. The cells showed an eosinophilic cytoplasm in the HE stain and a more or less basophilic cytoplasm in the Giemsa stain. Multinucleated giant cells were rare and mostly binucleated. Fine, fibrous septa separated the tumor cells into cell clusters.

Cleaved type (n = 2). This type was characterized by anisocytosis of the tumor cells with indented, cleaved nuclei, and an unusual perinuclear halo. The nuclear-to-cytoplasm ratio was 1:1. A considerable number of multinucleated giant cells with up to four nuclei were found. Fibrous septa separated the bandlike tumor-cell sheets. This type of tumor was nonencapsulated, and tumor cells infiltrated the surrounding tissue.

Asynchronous type (n = 4). The predominant characteristic of this type was a nuclear-cytoplasmic asynchrony in maturation. Although the tumor cells displayed some features of typical plasma cells, with an eosinophilic and marginally basophilic cytoplasm and a prominent perinuclear halo, they had blastic nuclei with a prominent central nucleolus (Fig. 1). In addition, numerous giant cells were observed. The distinctive fibrous stroma, with the formation of tumor-cell sheets, was identical to that of the cleaved type.

Polymorphous type (n = 1). This type was distinguished by its marked anisocytosis with polymorphous tumor cells and large numbers of giant cells with up to nine nuclei per profile. Generally, the cells had an eosinophilic cytoplasm that was basophilic in the Giemsa stain. Perinuclear halos were not present. The individual cells were round to oval in shape and often had eccentrically positioned nuclei with clearly recognizable nucleoli. The surrounding connective tissue was considerably infiltrated in the only EMP of this type.

Immunohistochemistry

Immunohistochemically, monoclonal {lambda} light-chain reactivity of the cytoplasm was ascertained in all nine tumors (Fig. 2). In addition, three cats also expressed the IgG heavy chain.

Amyloid was found in three EMPs in a diffuse pattern of distribution within the tumor tissue (Figs. 3, 4). Stained with Congo red, the amyloid deposits revealed the typical light-green birefringence when observed under polarized light (Figs. 5, 6). Two of the amyloid-containing EMPs were assigned to the asynchronous type, the third was of mature type. Immunohistochemistry showed that the amyloid deposits were AL{lambda}-amyloid (Fig. 7) in all the three cats.

Immunohistochemical examination for FeLV (p27 protein) was negative for all the tumors.


    Discussion
 Top
 Abstract
 Material and Methods
 Results
 Discussion
 References
 
In humans, the extramedullary plasmacytoma is uncommon and accounts for less than 5% of all plasmacellular neoplasia.7,29,30 Although EMPs are commonly found in dogs, mostly in the form of skin and mucosal neoplasms,20 they seem to be rare in cats. The latter conclusion can be drawn both from the fact that so far only single-case reports exist in the literature and from the incidence of cutaneous EMPs, as estimated from the number of biopsies submitted to this department for histologic examination. The incidence of EMPs in other parts of the body besides the skin remains unknown, although, according to other authors, it can be assumed to be low.4,5,13 From our own series, it also can be confirmed that EMPs in cats are mainly cutaneous neoplasms, as observed previously.4,5,9,13 The occurrence of EMPs in other organs, e.g., digestive tract 24,31 and liver,10 is rare. With an average age of 8.2 years, the EMP occurs predominantly in older cats. This, as well as the preference for the male sex, agrees with the result in the literature.4,5,13

As in dogs, a typing of EMPs based on morphologic criteria also is possible in cats. With the exception of the hyaline type described in dogs, the same types of EMP found in dogs were found in cats. The absent hyaline type might be found in cats, if a larger number of tumors could be examined. Because of the small number of cases and a lack of follow-up studies, no claim can be made currently concerning the diagnostic significance of the typing of feline EMPs.

Immunohistochemistry of the feline EMPs mainly revealed {lambda} light-chain expression. This is very similar to the physiologic distribution of light chains in normal feline plasma cells with primary expression of the {lambda} light chain.1 Monoclonal {kappa} light-chain expression was reported in only one case.9 With respect to the immunohistochemical results in our series, the possibility that the tumor plasma cells could express Ig heavy chains not detectable with the routinely used antibodies cannot be excluded.

According to the literature, amyloid is more frequently found in feline EMPs than in canine EMPs. Six out of 12 published cases of EMPs in cats report on amyloid deposits.4,5,14,19,24,28 In the present study, three of the nine EMPs contained amyloid, identified as AL{lambda}-amyloid. This is consistent with the result of the only study published to date of an immunohistochemically investigated feline EMP.24

As reported by other authors,5,10,14 immunohistochemical examination for FeLV-antigen (p27 protein) was negative for all tumors. Communication of the above results may contribute to the already existing knowledge regarding extramedullary plasmacytomas in cats.


    References
 Top
 Abstract
 Material and Methods
 Results
 Discussion
 References
 

  1. Arun SS, Breuer W, Hermanns W: Immunohistochemical examination of light-chain expression ({lambda}/{kappa} ratio) in canine, feline, equine, bovine and porcine plasma cells. J Vet Med A 43:573-576, 1996
  2. Bartl R, Frisch B, Fateh-Moghadam A, Kettner G, Jaeger K, Sommerfeld W: Histologic classification and staging of multiple myeloma. Am J Clin Pathol 87:342-355, 1987[ISI][Medline]
  3. Bataille R: Localized plasmacytomas. Clin Haematol 11:113-122, 1982[ISI][Medline]
  4. Breuer W, Colbatzky F, Platz S, Hermanns W: Immunoglobulin-producing tumors in dogs and cats. J Comp Pathol 109:203-216, 1993[ISI][Medline]
  5. Carothers MA, Johnson GC, DiBartola SP, Liepnicks J, Benson MD: Extramedullary plasmacytoma and immunoglobulin-associated amyloidosis in a cat. J Am Vet Med Assoc 195:1593-1597, 1989[ISI][Medline]
  6. Day MJ: Immunophenotypic characterization of cutaneous lymphoid neoplasia in the dog and cat. J Comp Pathol 112:79-96, 1995[CrossRef][ISI][Medline]
  7. Diebold J, Kremer M: Formenkreis der Plasmazellneoplasien—eine Uebersicht. In: Multiples Myelom; Empfehlungen zur Diagnostik, Therapie und Nachsorge. Tumorzentrum Muenchen, Munich, Germany, pp 7-12, 1998
  8. Jaeger E: Das extramedulläre Plasmocytom. Z Krebsforsch 52:349-383, 1942
  9. Kyriazidou A, Brown PJ, Lucke VM: Immunohistochemical staining of neoplastic and inflammatory plasma cell lesions in feline tissues. J Comp Pathol 100:337-341, 1989[CrossRef][ISI][Medline]
  10. Larsen AE, Carpenter JL: Hepatic plasmacytoma and biclonal gammopathy in a cat. J Am Vet Med Assoc 205:708-710, 1994[ISI][Medline]
  11. Lennert K, Feller AC: Histopathology of Non-Hodgkin's Lymphomas (Based on the updated Kiel-Classification), 2nd ed. Springer-Verlag, Berlin, Germany 1992
  12. Linke RP: Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence. Virchows Arch 436:439-448, 2000[CrossRef][ISI][Medline]
  13. Lucke VM: Primary cutaneous plasmacytomas in the dog and cat. J Small Anim Pract 28:49-55, 1987
  14. Mandel NS, Esplin DG: A retroperitoneal extramedullary plasmacytoma in a cat with a monoclonal gammopathy. J Am Anim Hosp Assoc 30:603-608, 1994
  15. Mathé G, Rappaport H, O'Conor GT, Torloni H: Histological and cytological typing of neoplastic diseases of haematopoietic and lymphoid tissues. In: International Histological Classification of Tumors, vol. 14, pp 39-40, World Health Organization, Geneva, Switzerland 1976
  16. Morton LD, Barton CL, Elissalde GS, Wilson SR: Oral extramedullary plasmacytomas in two dogs. Vet Pathol 23:637-639, 1986[ISI][Medline]
  17. Nakane PK, Pierce GB: Enzyme-labeled antibodies: preparation and application for the localization of antigens. J Histochem Cytochem 14:929-931, 1967
  18. Patterson JW, Parsons JM, White RM, Fitzpatrick JE, Kohout-Dutz E: Cutaneous involvement of multiple myeloma and extramedullary plasmacytoma. J Am Acad Dermatol 19:879-890, 1988[ISI][Medline]
  19. Platz SJ, Breuer W, Geisel O, Linke RP, Hermanns W: Identification of {lambda} light chain amyloid in eight canine and two feline extramedullary plasmacytomas. J Comp Pathol 116:45-54, 1997[CrossRef][ISI][Medline]
  20. Platz SJ, Breuer W, Pfleghaar S, Minkus G, Hermanns W: Prognostic value of histopathological grading in canine extramedullary plasmacytomas. Vet Pathol 36:23-27, 1999[Abstract]
  21. Puchtler H, Sweat F, Levine M: On the binding of Congo red by amyloid. J Histochem Cytochem 10:355-364, 1962[Abstract]
  22. Quaglino D, Hayhoe FGJ: Haematological Oncology, pp. 320-334, Churchill Livingstone, Edinburgh, UK 1992
  23. Rakich PM, Latimer KS, Weiss R, Steffens WL: Mucocutaneous plasmacytomas in dogs: 75 cases (1980–1987). J Am Vet Med Assoc 194:803-810, 1989[ISI][Medline]
  24. Rowland PH, Linke RP: Immunohistochemical characterization of lambda light-chain-derived amyloid in one feline and five canine plasma cell tumors. Vet Pathol 31:390-393, 1994[ISI][Medline]
  25. Rowland PH, Valentine BA, Stebbins KE, Smith CA: Cutaneous plasmacytoma with amyloid in six dogs. Vet Pathol 28:125-130, 1991[Abstract]
  26. Sandusky GE, Carlton WW, Wightman KA: Diagnostic immunohistochemistry of canine round cell tumors. Vet Pathol 24:495-499, 1987[Abstract]
  27. Trigo FJ, Hargis AM: Canine cutaneous plasmacytoma with regional lymph-node metastasis. Vet Med Small Anim Clin 78:1749-1751, 1983
  28. Ward DA, McEntee MF, Weddle DL: Orbital plasmacytoma in a cat. J Small Anim Pract 38:576-578, 1997[ISI][Medline]
  29. Wiltshaw E: The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine 55:217-238, 1976[Medline]
  30. Woodruff RK, Whittle JM, Malpas JS: Solitary plasmacytoma. I: extramedullary soft tissue plasmacytoma. Cancer 43:2340-2343, 1979[CrossRef][ISI][Medline]
  31. Zikes CD, Spielman B, Shapiro W, Roth L, Ablin L: Gastric extramedullary plasmacytoma in a cat. J Vet Intern Med 12:381-383, 1998[ISI][Medline]
Requests reprints from Dr. M. Majzoub, Institute of Veterinary Pathology, University of Munich, Veterinaerstrasse 13, D-80539, Munich (Germany).




This article has been cited by other articles:


Home page
Vet PatholHome page
P. J. Mellor, S. Haugland, K. C. Smith, R. M. Powell, J. Archer, T. J. Scase, E. J. Villiers, P. E. McNeil, C. Nixon, C. Knott, et al.
Histopathologic, Immunohistochemical, and Cytologic Analysis of Feline Myeloma-Related Disorders: Further Evidence for Primary Extramedullary Development in the Cat
Vet. Pathol., March 1, 2008; 45(2): 159 - 173.
[Abstract] [Full Text] [PDF]


Home page
jvdiHome page
S. Schoniger, N. Bridger, K. Allenspach, P. Mantis, J. Rest, and E. Steeves
Sinonasal plasmacytoma in a cat
J Vet Diagn Invest, September 1, 2007; 19(5): 573 - 577.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
J. A. Werner, J. C. Woo, W. Vernau, P. S. Graham, R. A. Grahn, L. A. Lyons, and P. F. Moore
Characterization of Feline Immunoglobulin Heavy Chain Variable Region Genes for the Molecular Diagnosis of B-cell Neoplasia
Vet. Pathol., September 1, 2005; 42(5): 596 - 607.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Majzoub, M.
Right arrow Articles by Hermanns, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Majzoub, M.
Right arrow Articles by Hermanns, W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS